A bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups.
Chemical ID:
MESH:C006780
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
bisphenol A results in increased expression of CASP3; bisphenol A results in increased expression of CASP3 mRNA; bisphenol A results in increased expression of CASP3 protein; bisphenol A results in increased expression of CASP3 protein modified form
18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of CASP3]; [bisphenol A co-treated with 4-nonylphenol] results in increased expression of CASP3 mRNA; [Genistein co-treated with bisphenol A] results in decreased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; bisphenol A inhibits the reaction [4-nonylphenol results in increased expression of CASP3 protein modified form]; bisphenol A inhibits the reaction [Genistein results in increased cleavage of CASP3 protein]; bisphenol A results in increased expression of and results in increased cleavage of CASP3 protein; Curcumin inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; Fluvastatin inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]; Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]]; Fulvestrant inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; Genistein inhibits the reaction [bisphenol A results in decreased cleavage of CASP3 protein]; Lycopene inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; Melatonin inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; NR4A1 protein inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; taxifolin inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [bisphenol A results in increased expression of and results in increased cleavage of CASP3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; [bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased cleavage of CASP3 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP3 protein; [Palmitates co-treated with bisphenol A] results in increased cleavage of CASP3 protein; [Streptozocin co-treated with bisphenol A] results in increased expression of CASP3 mRNA; Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; bisphenol A results in decreased expression of and results in decreased cleavage of CASP3 protein; bisphenol A results in increased expression of and results in decreased cleavage of CASP3 protein; bisphenol A results in increased expression of and results in increased cleavage of CASP3 protein; coenzyme Q10 inhibits the reaction [bisphenol A results in increased expression of CASP3 mRNA]; Imatinib Mesylate inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; KN 62 inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; KN 93 inhibits the reaction [bisphenol A results in increased expression of and results in increased cleavage of CASP3 protein]; Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased cleavage of CASP3 protein]; VDAC1 promotes the reaction [bisphenol A results in increased cleavage of CASP3 protein]; W 7 inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; W 7 inhibits the reaction [bisphenol A results in increased expression of and results in increased cleavage of CASP3 protein]
[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] inhibits the reaction [[bisphenol A co-treated with LEP protein] results in decreased activity of CASP3 protein]; [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] inhibits the reaction [[LEP protein co-treated with bisphenol A] results in decreased expression of CASP3 protein]; [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] inhibits the reaction [bisphenol A results in decreased activity of CASP3 protein]; [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] inhibits the reaction [bisphenol A results in decreased expression of CASP3 protein]; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [[LEP protein co-treated with bisphenol A] results in decreased activity of CASP3 protein]; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [[LEP protein co-treated with bisphenol A] results in decreased expression of CASP3 protein]; [bisphenol A co-treated with LEP protein] results in decreased expression of CASP3 mRNA; [bisphenol A co-treated with LEP protein] results in decreased expression of CASP3 protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CASP3 mRNA; benzyloxycarbonyltyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; bisphenol A promotes the reaction [LEP protein results in decreased activity of CASP3 protein]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of CASP3 protein]; LEP protein promotes the reaction [bisphenol A results in decreased activity of CASP3 protein]
